Foundation Grants
Community Vital Signs
About Us
As medical marijuana becomes more widely available in the US, one Canadian company is looking to take advantage.
Mydecine Innovations Group Inc.
has entered into subscription agreements with third-party investors to raise up to $3,750,000 through the sale of up to 18,750,000 common shares at a price of $0.20 per share, per a press release.
The company expects to close the deal on or about Sept.
16, 2023, per the release.
Mydecine, which is based in Vancouver, is a biotechnology company "engineering the next wave of innovative medications and treatment protocols to directly address mental health with a particular emphasis on addiction and PTSD," per the release.
Mydecine's lead product is MYCO-006, an analogue of the active ingredient in marijuana known as MDMA, or ecstasy, that has been shown to be effective in treating pain, anxiety, depression, addiction, and post-traumatic stress disorder, among other conditions.
Mydecine's CEO, Joshua Bartch, tells the CBC that the company's research and development team is working with artificial intelligence to create medications that are affordable to the general public upon FDA and Health Canada approval.
(New York Gov.
Andrew Cuomo has signed a bill making recreational marijuana legal in the state.
Read the Entire Article
Selected Foundation News
A customized collection of news from foundations from around the Web.
IDEA Bridge and IDEA Innovation, which opened in 2018, had more than 1,900 students enrolled in grades kindergarten to 12 at the time they called it quits.Colorado-based Third Futures Schools...more
The Wynne Yellowjackets soccer program will host a soccer camp from 6-8 p.m.Friday.The camp is open to all ages and skill levels.The program is based in the city's downtown area.For more information,...more
NYC Health + Hospitals expands youth mental health program, now totaling 4 locations.Stay Informed with Becker's Behavioral Health Newsletter.Use the weekly Newsquiz to test your knowledge of...more
Susana Van Der Ploeg calls for BRICS+ leadership in fostering equitable health governance, innovation, and civil society inclusion.She urges the bloc to adopt compulsory licensing, strengthen...more
Scientists at Goethe University have achieved a major breakthrough in PFAS degradation.Their newly developed catalyst breaks down PFAS compounds rapidly and efficiently.The process occurs in mere...more
The Circle of Life Award honors hospital and palliative care programs that are ensuring equitable access to care.The awards are cosponsored by the American Academy of Hospice and Palliative...more
Prism's ON3 campus welcomes 90,000 sq.ft.Hackensack Meridian Health facility.Four-story facility offers primary care, urgent care, rheumatology, gastroenterology, nephrology and orthopedic...more
Darren Ditto, Director, Clinical Information Systems Operations, received the Innovation Jago Award.The award is presented to an individual or team who exemplifies outstanding behaviours and actions...more
Study: Major Advances in EHR Usability and Clinician Satisfaction.Healthcare Innovation: EHRs are becoming more intuitive and intuitive to use and to understand.The EHR is becoming more and more...more
Boston Medical Center Health System Announces New Leadership Appointments and Expanded Roles to Support Integrated System Vision.Joe Camillus, MBA, MPH, has been named System Chief Operating Officer...more
Social Entrepreneurship
Spotlight
When it Comes to Social Enterprises, Failure is the Best Platform for Innovation
In the world of social enterprises, failure is a cringe-worthy moment nobody wants to talk about. But, social entrepreneurs can benefit from their failures.